Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation

NCT02325362 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Miglustat ; placebo
DRUG: Placebo ; Miglustat

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]
[object Object]